Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bladder Preservation Strategy with Intensified MVAC and TURB in Urothelial Carcinoma
NCT01093066Phase 2Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Sep 2010
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, vinblastine, doxorubicin, cisplatin in urothelial carcinoma (UC), sponsored by CHU Saint-Etienne. Started Sep 2010; status: terminated.
02
Drugs
methotrexatevinblastinedoxorubicincisplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01093066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093066.